(Total Views: 333)
Posted On: 09/03/2019 1:29:13 PM
Post# of 156422
Ohm , I have a question to you , so you thinking , if I understood well , when Leronlimab will be approved for MDR2 and MDR3 combo ,
with close to 190K ...RS- HIV strain... available patients only in USA , our pps should be about 1.50..?
I am not sure if you remember , when Ibalizumab was approved for MDR3 , with about 25,000 available patients in USA ,
I believe March of 2018 , THERF went as high as about or above 11.00 doll. .
One year before I think they were about 1-1.50.
Just curious ..
Thank you ..
with close to 190K ...RS- HIV strain... available patients only in USA , our pps should be about 1.50..?
I am not sure if you remember , when Ibalizumab was approved for MDR3 , with about 25,000 available patients in USA ,
I believe March of 2018 , THERF went as high as about or above 11.00 doll. .
One year before I think they were about 1-1.50.
Just curious ..
Thank you ..
(1)
(0)
